United States Trade Representative(@USTradeRep):Eli Lilly’s $5 BILLION investment to manufacture cancer drugs in Virginia is possible because of @POTUS’ competitive tax and trade policies. This new plant will create hundreds of jobs and strengthen the supply chains that patients and providers rely on. Today’s groundbreaking will ensure the United States can continue to lead in pharmaceutical innovation while strengthening its ability to produce life-saving “Made In America” medicines. To date, the Trump Administration has secured 26 deals with pharmaceutical manufacturers, including Eli Lilly, to manufacture in America and lower prescription drug prices for Americans. Branded drug prices have fallen over 3% year-over-year

United States Trade Representative@USTradeRep

2026.10.22 15:53

Eli Lilly’s $5 BILLION investment to manufacture cancer drugs in Virginia is possible because of @POTUS’ competitive tax and trade policies. This new plant will create hundreds of jobs and strengthen the supply chains that patients and providers rely on. Today’s groundbreaking will ensure the United States can continue to lead in pharmaceutical innovation while strengthening its ability to produce life-saving “Made In America” medicines. To date, the Trump Administration has secured 26 deals with pharmaceutical manufacturers, including Eli Lilly, to manufacture in America and lower prescription drug prices for Americans. Branded drug prices have fallen over 3% year-over-year — the steepest decline since 1963!